$14.64
-2.18-12.96%
At close: -
$14.71
0.070.48%
After Hours: 4:48 PM EDT
AnaptysBio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AnaptysBio using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $-0.72 | $-1.74 | 58.6 % |
Q3 | 2024-11-05 | $-1.14 | $-1.65 | 30.9 % |
Q2 | 2024-08-05 | $-1.71 | $-0.89 | -92.1 % |
Q1 | 2024-05-09 | $-1.64 | $-1.56 | -5.13 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $43.11M | $10.09M | 327.3 % |
Q3 | 2024-11-05 | $30.02M | $6.87M | 336.7 % |
Q2 | 2024-08-05 | $10.97M | $24.30M | -54.9 % |
Q1 | 2024-05-09 | $7.18M | $3.72M | 93.0 % |
AnaptysBio (ANAB) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
The Actual EPS was $-0.72, which beat the estimate of $-1.74.
The Actual Revenue was $43.1M, which beat the estimate of $10.1M.
Browse earnings estimates, EPS, and revenue on all stocks.